Evidence map›Paper›PMID 21646391›Full record

ArticleReproduction (Cambridge, England)2011

Excessive ovarian production of nerve growth factor elicits granulosa cell apoptosis by setting in motion a tumor necrosis factor α/stathmin-mediated death signaling pathway.

Cecilia Garcia-Rudaz, Mauricio Dorfman, Srinivasa Nagalla, Konstantin Svechnikov, Olle Söder, Sergio R Ojeda, Gregory A Dissen

Open access · bronzeAbstract read
In one paragraph

Article in Reproduction (Cambridge, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Cecilia Garcia-RudazDivision of Neuroscience, Oregon National Primate Research Center-Oregon Health and Science University, Beaverton, Oregon 97006, USA.
Mauricio Dorfman
Srinivasa Nagalla
Konstantin Svechnikov
Olle Söder
Sergio R Ojeda
Gregory A Dissen
Oregon Health & Science University · USKarolinska Institutet · SEOregon National Primate Research Center · US

Funding

YR 50 PROJ- ROBERTS PRIMATE ISLETP51RR000163 · NCRR · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI FRUH, KLAUS J · 1985 to 2011
$140.8M
VASOACTIVE FACTORS IN ART CYCLES AND OVARIAN HYPERSTIMULATION SYNDROMEU54HD018185 · NICHD · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI BETHEA, CYNTHIA LOUISE · 1999 to 2010
$13.8M
NEURAL CONTROL OF THE PREPUBERTAL OVARYR01HD024870 · NICHD · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI OJEDA, SERGIO R · 1988 to 2011
$4.1M
INTERNATIONAL TRAINING &RESEARCH IN POPULATION &HEALTHD43TW000668 · FIC · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI CONN, P. MICHAEL · 1995 to 2010
$2.1M
REPRODUCTIVE STEROIDS AND EXPERIMENTAL STROKEK01RR000163 · NCRR · OREGON HEALTH AND SCIENCE UNIVERSITY · PI MURPHY, STEPHANIE J · 2000 to 2004
$479k
REPRODUCTIVE BIOLOGY IN PRIMATES: CENTER FACILITIESP30HD018185 · NICHD · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI SPIES, HAROLD G · 1985 to 1998
–
FIC NIH HHS D43 TW000668NCRR NIH HHS K01 RR000163NCRR NIH HHS P51 RR000163NICHD NIH HHS HD18185NICHD NIH HHS HD24870NICHD NIH HHS P30 HD018185NICHD NIH HHS R01 HD024870NICHD NIH HHS TW/HD00668NICHD NIH HHS U54 HD018185
6 · The paper itself

Abstract

Excessive nerve growth factor (NGF) production by the ovary, achieved via a transgenic approach, results in arrested antral follicle growth, reduced ovulatory capacity, and a predisposition to cyst formation in response to mildly elevated LH levels. Two salient features in these mutant mice (termed 17NF) are an elevated production of 17α-hydroxyprogesterone (17-OHP(4)), testosterone, and estradiol (E(2)) in response to gonadotropins, and an increased frequency of granulosa cell (GC) apoptosis. In this study, we show that the increase in steroidal response is associated with enhanced expression of Cyp17a1, Hsd17b, and Cyp19a1, which encode the enzymes catalyzing the synthesis of 17-OHP(4), testosterone, and E(2) respectively. Using a proteomic approach, we identified stathmin (STMN1), as a protein that is overproduced in 17NF ovaries. In its phosphorylated state, STMN1 mediates a cell death signal initiated by tumor necrosis factor α (TNF). STMN1 is expressed in GCs and excessive NGF increases its abundance as well as that of its forms phosphorylated at serine (Ser) 16, 25, and 38. TNF synthesis is also increased in 17NF ovaries, and this change is abolished by blocking neurotrophic tyrosine kinase receptors. Inhibiting TNF actions in vivo by administering a soluble TNF receptor prevented the increase in total and phosphorylated STMN1 production, as well as GC apoptosis in NGF-overproducing ovaries. These results indicate that an excess of NGF in the ovary promotes steroidogenesis by enhancing the expression of enzyme genes involved in 17-OHP(4), testosterone, and E(2) synthesis, and causes GC apoptosis by activating a TNF/ STMN1-mediated cell death pathway.

Indexed as

ApoptosisSignal Transduction17-Hydroxysteroid DehydrogenasesAnimalsAromataseFemaleGene Expression RegulationGonadal Steroid HormonesGonadotropinsGranulosa CellsIsoenzymesMiceMice, TransgenicNerve Growth FactorOvaryPhosphorylation17-Hydroxysteroid DehydrogenasesAromataseGonadal Steroid HormonesGonadotropinsIsoenzymesNerve Growth FactorRNA, MessengerStathminSteroid 17-alpha-HydroxylaseStmn1 protein, mouseTumor Necrosis Factor-alpha

Identifiers

PMID21646391
PMCPMC3302175
OpenAlexW2039466751

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.